Candace Roberts – CLARICO Study

Skip to content

Change font size

CLARICO Study

Living with Primary Photoreceptor Disease
About the Study Drug
Study Eligibility
Study Details

Living with Primary Photoreceptor Disease
About the Study Drug
Study Eligibility
Study Details

Nothing Found

OpCT-001 is currently being studied and is not approved for use in any country.

The sponsor of the CLARICO study is BlueRock Therapeutics.

BlueRock Therapeutics
238 Main Street, 3rd Floor
Cambridge, MA 02142

Change font size

Original
Large
Extra Large

Privacy policy
Terms of use
Accessibility

MED-CA-OPH-2500001v2 (12/25)

© Copyright 2026 | BlueRock Therapeutics | All Rights Reserved